Rethinking proton pump inhibitor deprescribing: from tapering strategies to patient-centered management
Journal of Gastroenterology · 2026-08 · 61 (8) · 1184-1186
DOI: 10.1007/s00535-026-02475-5 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Gastroenterology, online erschienen am 27.06.2026. Verfasst von Kenta Watanabe und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. nabeken@med.akita-u.ac.jp. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan. nabeken@med.akita-u.ac.jp.
- Department of Gastroenterology, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.
Zitieren
APA
Watanabe, K., & Iijima, K. (2026). Rethinking proton pump inhibitor deprescribing: from tapering strategies to patient-centered management. Journal of Gastroenterology, 61(8), 1184-1186. https://doi.org/10.1007/s00535-026-02475-5
Vancouver
Watanabe K, Iijima K. Rethinking proton pump inhibitor deprescribing: from tapering strategies to patient-centered management. Journal of Gastroenterology. 2026;61(8):1184-1186. doi:10.1007/s00535-026-02475-5
BibTeX
@article{Watanabe2026,
author = {Watanabe, Kenta and Iijima, Katsunori},
title = {Rethinking proton pump inhibitor deprescribing: from tapering strategies to patient-centered management},
journal = {Journal of Gastroenterology},
year = {2026},
volume = {61},
number = {8},
pages = {1184--1186},
doi = {10.1007/s00535-026-02475-5}
}
EUVIMED